Breast tomosynthesis exams — Hologic calls them 3D Mammography — have shown to be an advance over digital mammography, with higher
cancer detection rates and fewer patient recalls for additional testing. The new Affirm Prone Biopsy system, which was installed for the first
time in Europe earlier this year, is widely considered as one of the most significant advances in biopsy technology since the first prone biopsy
system was introduced more than 20 years ago.